|
1
|
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.
|
Nat Genet
|
2009
|
14.86
|
|
2
|
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
|
Nat Genet
|
2011
|
9.23
|
|
3
|
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
|
J Am Geriatr Soc
|
2008
|
2.05
|
|
4
|
Addition of the multidimensional prognostic index to the estimated glomerular filtration rate improves prediction of long-term all-cause mortality in older patients with chronic kidney disease.
|
Rejuvenation Res
|
2012
|
1.51
|
|
5
|
Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging.
|
Neurobiol Aging
|
2005
|
1.46
|
|
6
|
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial.
|
Phys Ther
|
2009
|
1.35
|
|
7
|
Comparing the prognostic accuracy for all-cause mortality of frailty instruments: a multicentre 1-year follow-up in hospitalized older patients.
|
PLoS One
|
2012
|
1.32
|
|
8
|
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
|
Ageing Res Rev
|
2010
|
1.30
|
|
9
|
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.
|
J Alzheimers Dis
|
2010
|
1.19
|
|
10
|
The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia.
|
J Alzheimers Dis
|
2009
|
1.16
|
|
11
|
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms.
|
J Alzheimers Dis
|
2010
|
1.06
|
|
12
|
Dietary fatty acids intake: possible role in cognitive decline and dementia.
|
Exp Gerontol
|
2005
|
1.06
|
|
13
|
Lifestyle-related factors in predementia and dementia syndromes.
|
Expert Rev Neurother
|
2008
|
1.06
|
|
14
|
Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology.
|
Prog Lipid Res
|
2011
|
1.05
|
|
15
|
Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?
|
Expert Opin Investig Drugs
|
2011
|
1.04
|
|
16
|
Circulating biomarkers of cognitive decline and dementia.
|
Clin Chim Acta
|
2005
|
1.03
|
|
17
|
Diet and Alzheimer's disease risk factors or prevention: the current evidence.
|
Expert Rev Neurother
|
2011
|
1.03
|
|
18
|
Metabolic syndrome as a risk factor for neurological disorders.
|
Cell Mol Life Sci
|
2011
|
1.01
|
|
19
|
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations.
|
Neurobiol Aging
|
2011
|
1.00
|
|
20
|
Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?
|
Front Aging Neurosci
|
2010
|
0.98
|
|
21
|
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease.
|
Ageing Res Rev
|
2009
|
0.98
|
|
22
|
Solanezumab for the treatment of mild-to-moderate Alzheimer's disease.
|
Expert Rev Clin Immunol
|
2012
|
0.97
|
|
23
|
Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy.
|
J Gerontol A Biol Sci Med Sci
|
2006
|
0.97
|
|
24
|
Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging.
|
Neurobiol Aging
|
2009
|
0.96
|
|
25
|
Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?
|
J Alzheimers Dis
|
2010
|
0.96
|
|
26
|
Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing.
|
J Neurol Neurosurg Psychiatry
|
2009
|
0.93
|
|
27
|
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia.
|
J Rehabil Med
|
2009
|
0.93
|
|
28
|
Mediterranean diet, mild cognitive impairment, and Alzheimer's disease.
|
Exp Gerontol
|
2006
|
0.92
|
|
29
|
Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Aging.
|
Alzheimers Dement
|
2012
|
0.92
|
|
30
|
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.
|
Age (Dordr)
|
2011
|
0.92
|
|
31
|
Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms.
|
Ageing Res Rev
|
2009
|
0.92
|
|
32
|
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment.
|
J Alzheimers Dis
|
2010
|
0.91
|
|
33
|
The genetics of the human APOE polymorphism.
|
Rejuvenation Res
|
2011
|
0.91
|
|
34
|
The RELN locus in Alzheimer's disease.
|
J Alzheimers Dis
|
2008
|
0.91
|
|
35
|
The APOE gene locus in frontotemporal dementia and primary progressive aphasia.
|
Arch Neurol
|
2011
|
0.90
|
|
36
|
SBOTE study: extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial.
|
Ultrasound Med Biol
|
2012
|
0.90
|
|
37
|
A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack.
|
J Neurol
|
2011
|
0.90
|
|
38
|
Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
|
Curr Alzheimer Res
|
2012
|
0.89
|
|
39
|
Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the Italian longitudinal study on aging.
|
Dement Geriatr Cogn Disord
|
2007
|
0.89
|
|
40
|
Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
|
Exp Gerontol
|
2004
|
0.88
|
|
41
|
Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease.
|
Rejuvenation Res
|
2010
|
0.87
|
|
42
|
Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
|
Dement Geriatr Cogn Disord
|
2007
|
0.87
|
|
43
|
Nutritional factors, cognitive decline, and dementia.
|
Brain Res Bull
|
2005
|
0.86
|
|
44
|
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis.
|
J Neurol
|
2014
|
0.85
|
|
45
|
Effectiveness of the frequency rhythmic electrical modulation system for the treatment of chronic and painful venous leg ulcers in older adults.
|
Rejuvenation Res
|
2012
|
0.85
|
|
46
|
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging.
|
Age (Dordr)
|
2011
|
0.85
|
|
47
|
Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report.
|
J Chiropr Med
|
2010
|
0.84
|
|
48
|
Pharmacogenetics of cytochrome P450 (CYP) in the elderly.
|
Ageing Res Rev
|
2010
|
0.84
|
|
49
|
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease.
|
J Neurol
|
2010
|
0.83
|
|
50
|
Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging.
|
Exp Gerontol
|
2006
|
0.83
|
|
51
|
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
|
Expert Opin Drug Discov
|
2011
|
0.83
|
|
52
|
Usefulness of the multidimensional prognostic index (MPI) in the management of older patients with chronic kidney disease.
|
J Nephrol
|
2012
|
0.82
|
|
53
|
Effectiveness of switching therapy from complexing protein-containing botulinum toxin type A to a formulation with low immunogenicity in spasticity after stroke: a case report.
|
J Rehabil Med
|
2012
|
0.82
|
|
54
|
Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer's disease.
|
J Am Geriatr Soc
|
2007
|
0.82
|
|
55
|
The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
|
Int J Geriatr Psychiatry
|
2010
|
0.82
|
|
56
|
Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2008
|
0.81
|
|
57
|
Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads.
|
Expert Opin Biol Ther
|
2011
|
0.81
|
|
58
|
A multidimensional prognostic index in common conditions leading to death in older patients.
|
Arch Intern Med
|
2012
|
0.81
|
|
59
|
Adherence to a Mediterranean dietary pattern and risk of Alzheimer's disease.
|
Ann Neurol
|
2006
|
0.81
|
|
60
|
Effect of donepezil on the continuum of depressive symptoms, mild cognitive impairment, and progression to dementia.
|
J Am Geriatr Soc
|
2010
|
0.81
|
|
61
|
Interleukin 6-174 G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles.
|
Exp Gerontol
|
2004
|
0.81
|
|
62
|
Apolipoprotein E, dementia, and human longevity.
|
J Am Geriatr Soc
|
2009
|
0.81
|
|
63
|
Selective attention skills in differentiating between Alzheimer's disease and normal aging.
|
J Geriatr Psychiatry Neurol
|
2002
|
0.80
|
|
64
|
LRP-1 variation is not associated with risk of Alzheimer's disease.
|
Int J Mol Epidemiol Genet
|
2010
|
0.80
|
|
65
|
Current knowledge of chromosome 12 susceptibility genes for late-onset Alzheimer's disease.
|
Neurobiol Aging
|
2005
|
0.80
|
|
66
|
Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease.
|
Neurosci Lett
|
2008
|
0.80
|
|
67
|
Apolipoprotein E genotypes in mild cognitive impairment subtypes.
|
J Am Geriatr Soc
|
2006
|
0.80
|
|
68
|
Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
|
Atherosclerosis
|
2005
|
0.80
|
|
69
|
Diet, cholesterol metabolism, and Alzheimer's disease: Apolipoprotein E as a possible link?
|
J Am Geriatr Soc
|
2006
|
0.80
|
|
70
|
The cathepsin D gene exon 2 (C224T) polymorphism and sporadic Alzheimer's disease in European populations.
|
J Gerontol A Biol Sci Med Sci
|
2005
|
0.80
|
|
71
|
Unsaturated fatty acids intake and all-causes mortality: a 8.5-year follow-up of the Italian Longitudinal Study on Aging.
|
Exp Gerontol
|
2005
|
0.79
|
|
72
|
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke.
|
J Neural Transm (Vienna)
|
2012
|
0.79
|
|
73
|
Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms.
|
Neurosci Lett
|
2007
|
0.79
|
|
74
|
Mediterranean dietary pattern, mild cognitive impairment, and progression to dementia.
|
Arch Neurol
|
2009
|
0.79
|
|
75
|
Hypertension and mild cognitive impairment subtypes.
|
Arch Neurol
|
2008
|
0.78
|
|
76
|
Polymorphisms in the oxidized low-density lipoprotein receptor-1 gene and risk of Alzheimer's disease.
|
J Gerontol A Biol Sci Med Sci
|
2005
|
0.78
|
|
77
|
Dietary patterns and protection against Alzheimer disease and cognitive decline.
|
Arch Neurol
|
2010
|
0.78
|
|
78
|
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2009
|
0.78
|
|
79
|
Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.
|
J Rehabil Med
|
2010
|
0.78
|
|
80
|
TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia.
|
J Alzheimers Dis
|
2012
|
0.78
|
|
81
|
Prevalence of aging-associated cognitive decline in an Italian elderly population: results from cross-sectional phase of Italian PRoject on Epidemiology of Alzheimer's disease (IPREA).
|
Aging Clin Exp Res
|
2010
|
0.78
|
|
82
|
Klotho locus, metabolic traits, and serum hemoglobin in hospitalized older patients: a genetic association analysis.
|
Age (Dordr)
|
2011
|
0.78
|
|
83
|
Dietary fatty acids and predementia syndromes.
|
ScientificWorldJournal
|
2009
|
0.78
|
|
84
|
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults.
|
Audiol Neurootol
|
2015
|
0.78
|
|
85
|
Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or =65 years of age (The Italian Longitudinal Study on Aging).
|
Am J Cardiol
|
2002
|
0.78
|
|
86
|
Vascular factors predict polyneuropathy in a non-diabetic elderly population.
|
Neurol Sci
|
2012
|
0.77
|
|
87
|
Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia.
|
Dement Geriatr Cogn Disord
|
2010
|
0.77
|
|
88
|
Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients.
|
Age (Dordr)
|
2010
|
0.77
|
|
89
|
Genetic variation in MME in relation to neprilysin protein and enzyme activity, Aβ levels, and Alzheimer's disease risk.
|
Int J Mol Epidemiol Genet
|
2012
|
0.77
|
|
90
|
Possible role of alpha-lipoic acid in the treatment of peripheral nerve injuries.
|
J Brachial Plex Peripher Nerve Inj
|
2010
|
0.77
|
|
91
|
Whole-diet approach: working on a criterion validity for age-related cognitive decline and mild cognitive impairment.
|
J Am Geriatr Soc
|
2009
|
0.77
|
|
92
|
Plasma lipid disturbances and cognitive decline.
|
J Am Geriatr Soc
|
2010
|
0.77
|
|
93
|
Progression to dementia in probable and possible mild cognitive impairment.
|
Arch Neurol
|
2007
|
0.77
|
|
94
|
Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia?
|
J Am Geriatr Soc
|
2008
|
0.77
|
|
95
|
Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.
|
Curr Drug Metab
|
2011
|
0.77
|
|
96
|
Treatment of late-life major depressive disorder with selective serotonin reuptake inhibitors improves the multidimensional prognostic index.
|
J Clin Psychopharmacol
|
2012
|
0.77
|
|
97
|
Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty.
|
Orthopedics
|
2009
|
0.77
|
|
98
|
Whole-diet approach and risk of chronic disease: Limits and advantages.
|
J Am Geriatr Soc
|
2006
|
0.77
|
|
99
|
Late-life depression and Alzheimer's disease: the glutamatergic system inside of this mirror relationship.
|
Brain Res Rev
|
2011
|
0.77
|
|
100
|
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages.
|
Atherosclerosis
|
2006
|
0.77
|
|
101
|
Italian Project on Epidemiology of Alzheimer's disease (I.PR.E.A.): study design and methodology of cross-sectional survey.
|
Aging Clin Exp Res
|
2005
|
0.77
|
|
102
|
Semantic dementia: neuropsychological and behavioral patterns in relation to hemispheric asymmetries.
|
Am J Geriatr Psychiatry
|
2003
|
0.76
|
|
103
|
Serum total cholesterol as a biomarker for Alzheimer's disease: mid-life or late-life determinations?
|
Exp Gerontol
|
2006
|
0.76
|
|
104
|
Lifestyle-related factors, alcohol consumption, and mild cognitive impairment.
|
J Am Geriatr Soc
|
2007
|
0.76
|
|
105
|
Measuring pharmacogenetics in special groups: geriatrics.
|
Expert Opin Drug Metab Toxicol
|
2015
|
0.76
|
|
106
|
Moderate alcohol consumption, apolipoprotein E, and neuroprotection.
|
Arch Neurol
|
2009
|
0.76
|
|
107
|
All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a).
|
Rejuvenation Res
|
2009
|
0.76
|
|
108
|
Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia.
|
J Alzheimers Dis
|
2006
|
0.76
|
|
109
|
Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
|
J Rehabil Med
|
2008
|
0.76
|
|
110
|
Possible role of unsaturated fatty acids in a 14-day healthy longevity lifestyle program.
|
Am J Geriatr Psychiatry
|
2007
|
0.75
|
|
111
|
Prevalence rates of mild cognitive impairment subtypes and progression to dementia.
|
J Am Geriatr Soc
|
2006
|
0.75
|
|
112
|
Alcohol use, thiamine deficiency, and cognitive impairment.
|
JAMA
|
2008
|
0.75
|
|
113
|
Low incidence for predementia and dementia syndromes in a brain imaging study.
|
Ann Neurol
|
2006
|
0.75
|
|
114
|
Cardiovascular factors and cognitive impairment: a role for unsaturated fatty acids and Mediterranean diet?
|
Am J Cardiol
|
2006
|
0.75
|
|
115
|
Whole-diet approach, Mediterranean diet, and Alzheimer disease.
|
Arch Neurol
|
2007
|
0.75
|
|
116
|
N-3 polyunsaturated fatty acids and statins in heart failure.
|
Lancet
|
2009
|
0.75
|
|
117
|
Stroke and memory decline: a question of degenerative or vascular origin.
|
Arch Neurol
|
2006
|
0.75
|
|
118
|
Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.
|
Age (Dordr)
|
2010
|
0.75
|
|
119
|
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial.
|
J Orthop Sports Phys Ther
|
2016
|
0.75
|
|
120
|
Botulinum toxin type A in the treatment of focal hand dystonia after surgical treatment for thumb duplication.
|
Orthopedics
|
2009
|
0.75
|
|
121
|
Change of diagnoses in probable and possible mild cognitive impairment: the Italian Longitudinal Study on Aging.
|
J Am Geriatr Soc
|
2007
|
0.75
|
|
122
|
The Role of Hearing Impairment in Cognitive Decline: Need for the Special Sense Assessment in Evaluating Cognition In Older Age.
|
Neuroepidemiology
|
2016
|
0.75
|
|
123
|
Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome).
|
Pain Med
|
2009
|
0.75
|
|
124
|
Phytochemicals in the Treatment of Alzheimer's Disease: A Systematic Review.
|
Curr Drug Targets
|
2016
|
0.75
|
|
125
|
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure.
|
J Am Geriatr Soc
|
2008
|
0.75
|
|
126
|
Pharmacogenetics in Neurodegenerative Diseases: Implications for Clinical Trials.
|
Front Neurol Neurosci
|
2016
|
0.75
|
|
127
|
Possible predictors of vascular cognitive impairment-no dementia.
|
J Am Geriatr Soc
|
2009
|
0.75
|
|
128
|
[Predementia syndromes and mild cognitive impairment: diagnosis and progression to dementia].
|
Recenti Prog Med
|
2007
|
0.75
|
|
129
|
Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke.
|
Brain Inj
|
2010
|
0.75
|
|
130
|
The serotonin transporter gene locus in late-life major depressive disorder.
|
Am J Geriatr Psychiatry
|
2013
|
0.75
|
|
131
|
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus?
|
J Rehabil Med
|
2009
|
0.75
|
|
132
|
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease.
|
Neurobiol Aging
|
2008
|
0.75
|
|
133
|
Plasma levels of n-3 polyunsaturated fatty acids and cognitive decline: possible role of depressive symptoms and apolipoprotein E genotyping.
|
J Am Geriatr Soc
|
2010
|
0.75
|
|
134
|
Dietary polyunsaturated fatty acid supplementation, pre-dementia syndromes, and Alzheimer's disease.
|
J Am Geriatr Soc
|
2007
|
0.75
|
|
135
|
[Forkhead-box-O1 locus and metabolic markers in the elderly: an association study].
|
Rev Esp Geriatr Gerontol
|
2012
|
0.75
|
|
136
|
Effect of botulinum toxin type A and modified constraint-induced movement therapy on motor function of upper limb in children with obstetrical brachial plexus palsy.
|
Childs Nerv Syst
|
2011
|
0.75
|
|
137
|
[Depression in old age: a diagnostic and therapeutic challenge].
|
Recenti Prog Med
|
2007
|
0.75
|